A taxonomy of reasons for not prescribing guideline-recommended medications for patients with heart failure
References (37)
- et al.
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction
Am J Cardiol
(1997) - et al.
Cancer screening in elderly patients: A framework for individualized decision making
JAMA
(2001) Performance measurement in search of a path
N Engl J Med
(2007)- et al.
The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure
Ann Intern Med
(2008) - et al.
Building a better quality measure: Are some patients with ‘poor quality’ actually getting good care?
Med Care
(2003) - et al.
Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus?
J Am Geriatr Soc
(2005) - et al.
The ambiguous relation between aging and adverse drug reactions
Ann Intern Med
(1991) Medical care for the final years of life: “When you're 83, it's not going to be 20 years”
JAMA
(2009)- et al.
Why don't physicians follow clinical practice guidelines? A framework for improvement
JAMA
(1999) - et al.
Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review
BMC Med Inform Decis Mak
(2008)
Thou shalt versus thou shalt not: A meta-synthesis of GPs' attitudes to clinical practice guidelines
Br J Gen Pract
(2007)
The impact of physician attitudes and beliefs on treatment decisions: Lipid therapy in high-risk patients
Med Care
(2006)
Why general practitioners do not implement evidence: Qualitative study
BMJ
(2001)
Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model
J Gen Intern Med
(2003)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society
Circulation
(2005)
Barriers to accurate diagnosis and effective management of heart failure in primary care: Qualitative study
BMJ
(2003)
Medical decision making in situations that offer multiple alternatives
JAMA
(1995)
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: A qualitative study
BMC Fam Pract
(2009)
Cited by (23)
Heart Failure Management in Nursing Homes: A Scoping Literature Review
2018, Canadian Journal of CardiologyTherapy modifications during hospitalization in patients with chronic heart failure
2016, European Journal of Internal MedicineCitation Excerpt :A “treatment gap” might also occur in some of these patients, who are not treated despite being eligible [22]. Other possible reasons such as polypharmacy, age, or socio-medical reasons [12,14] could have also contributed to physicians' decisions but were not documented. Similar reasons could explain why not many of the patients reached target doses and why down-titration was common.
The journey of the frail older adult with heart failure: Implications for management and health care systems
2014, Reviews in Clinical GerontologyClinician challenges to evidence-based prescribing for heart failure and reduced ejection fraction: A qualitative evaluation
2023, Journal of Evaluation in Clinical PracticeA machine learning evaluation of patient characteristics associated with prescribing of guideline-directed medical therapy for heart failure
2023, Frontiers in Cardiovascular Medicine
Presented at the American Geriatrics Society 2009 Annual Scientific Meeting, April 29–May 3, 2009, Chicago, Illinois; and the Society of General Internal Medicine 32nd Annual Meeting, May 13–16, 2009, Miami Beach, Florida.
Copyright © 2010 Published by Elsevier Inc.